- Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling
Najah Albadari et al, 2024, Frontiers in Pharmacology CrossRef - FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
Jakub Szymczyk et al, 2021, Cancers CrossRef - Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers
Khine S. Shan et al, 2024, International Journal of Molecular Sciences CrossRef - Targeting the Fibroblast Growth Factor Receptor (FGFR) Family in Lung Cancer
Laura Pacini et al, 2021, Cells CrossRef - From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor
Lewis D. Turner et al, 2022, Journal of Medicinal Chemistry CrossRef - The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention
Subhasmita Mahapatra et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef - Steroid-induced fibroblast growth factors drive an epithelial-mesenchymal inflammatory axis in severe asthma
Riccardo Guidi et al, 2022, Science Translational Medicine CrossRef - 2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology
Richard J. Epstein et al, 2021, Journal of Oncology CrossRef - EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges
Balakarthikeyan Janani et al, 2022, Vaccines CrossRef - Open-label, dose-escalation FIGHT-101 study of pemigatinib combined with targeted therapy, chemotherapy, or immunotherapy in patients with advanced malignancies
M. Saleh et al, 2024, ESMO Open CrossRef - FGFR inhibitors: Emerging treatments in advanced or metastatic cholangiocarcinoma
Yasar Ahmed et al, 2021, Journal of Current Oncology CrossRef - Emerging genetic biomarkers in lung adenocarcinoma
Jawad Barbar et al, 2022, SAGE Open Medicine CrossRef